The World Trade Organization group on intellectual property rights met 2 March and ended early, discussing a potential workshop on an amendment intended to ease access to cheaper generic medicines in countries without a pharmaceutical manufacturing sector, a new proposal from Bolivia, and three separate longstanding IP [intellectual property] issues with no major changes.

Countries were unable to agree to hold a workshop on the so-called “paragraph 6” agreement, which allow countries to issue a compulsory license on drugs primarily intended for export to developing countries in need of cheaper generic versions and unable to manufacture them themselves.

Instead, the chair of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council said he will hold informal consultations on the issue, though the details of when and how they will be conducted are not yet decided. The United States appears to be the main opponent of holding a workshop, according to several sources. For more background on this issue, see (IPW, WTO/TRIPS, 1 March 2010).

Several countries also brought up another health issue in order to signal its continuing importance to their delegations, sources said. This issue is the delaying of generic drugs in transit through European ports, on which positions have remained unchanged since the October 2009 TRIPS Council (IPW, WTO/TRIPS, 30 October 2009).

Bolivia Proposal

Bolivia has submitted a communication on the article in the TRIPS agreement related to plant variety protection and the patentability of innovations on plants and animals.

This TRIPS Article 27.3(b) was scheduled to be reviewed four years after the implementation of the agreement forming the WTO. But that review stalled and the last official document on it [pdf] dates to March 2006.

More recently, issues of patenting related to plant life have been discussed in relation to a mandate from the 2001 Doha ministerial that the TRIPS Council examine the relationship of TRIPS to the Convention on Biological Diversity (CBD).

The Bolivia submission is related to the country’s adoption of a new constitution in January 2009 that includes provisions on the rights of indigenous peoples, the protection of biodiversity and “prohibition of private appropriation of plants, animals, micro-organisms and any living matter for exclusive use and exploitation.”

Article 27.3(b) does not allow the flexibility not to grant patents on micro-organisms.

Bolivia’s communication also cites the UN Declaration on the Rights of Indigenous Peoples, and says a review of 27.3(b) should take this declaration into account.

It calls for 27.3(b) to prohibit the patenting of life forms, including micro-organisms and gene sequences, ensure the protection of indigenous and local community traditional knowledge and folklore in particular against IP claims over that knowledge, and prevent “anti-competitive practices” that threaten food sovereignty in developing countries.

Kaitlin Mara may be reached at kmara@ip-watch.ch.